Cross-source evidence timeline

Apraglutide research timeline

Follow 8 selected, directly cited source records from October 24, 2024 through August 4, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

8Selected records
3Source years
1Evidence lanes
August 4, 2026Latest source date

Source year

2026

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT07742735↗

    PeptideScanner retained ClinicalTrials.gov record NCT07742735 at 2026-11-16T01:47:19.543Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was apraglutide.↗

Source year

2025

3 records
  1. Clinical trials

    ClinicalTrials.gov record NCT05706623↗

    PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT05018286↗

    PeptideScanner retained ClinicalTrials.gov record NCT05018286 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was apraglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT04964986↗

    PeptideScanner retained ClinicalTrials.gov record NCT04964986 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-06-18, and PeptideScanner's reviewed identity mapping was apraglutide.↗

Source year

2024

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT04627025↗

    PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT04699032↗

    PeptideScanner retained ClinicalTrials.gov record NCT04699032 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT06002555↗

    PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT05995704↗

    PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.↗